Antibacterial & antiplasmid activities of Helicteres isora L

Indian Journal of Medical Research

Volumn 132, Issue 7, 2010, Pages 94-99

  Shriram, Varsha ^a,f   Jahagirdar, Sheetal ^b   Latha, C ^c   Kumar, Vinay ^d   Dhakephalkar, Prashant ^b   Rojatkar, Supad ^e   Shitole, Mahadeo G ^a  

^a UNIVERSITY OF PUNE   (India)

^b AGHARKAR RESEARCH INSTITUTE   (India)

^c INDIAN INSTITUTE OF SCIENCE   (India)

^d Department of Biotechnology   (India)

^e NATIONAL CHEMICAL LABORATORY   (India)

^f Annasaheb Magar College   (India)

Author keywords

Antibacterial activity; Antibiotic resistance; Antiplasmid activity; Helicteres isora; Multiple drug resistance; Plasmid curing

Indexed keywords

ANTIINFECTIVE AGENT; HELICTERES ISORA EXTRACT; PLANT EXTRACT; PLASMID DNA; UNCLASSIFIED DRUG; ACETONE;

AGAR GEL ELECTROPHORESIS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS CEREUS; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HELICTERES ISORA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; R PLASMID; STERCULIACEAE; CHEMISTRY; DRUG EFFECT; FRACTIONATION; FRUIT; GENETICS; INDIA; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; R FACTOR;

ACETONE; BACILLUS CEREUS; CHEMICAL FRACTIONATION; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, AGAR GEL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FRUIT; INDIA; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; R FACTORS; STERCULIACEAE;

EID: 77954445599     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. nd ed. Allahabad, India: Lalit Mohan Basu; 1981.
2. Kumar G, Banu GS, Murugesan AG, Pandian MR. Hypoglycaemic effect of Helicteres isora bark extract in rats. J Ethnopharmacol 2006; 107: 304-7.
3. Venkatesh S, Laxmi KS, Reddy BM, Ramesh M. Antinociceptive activity of Helicteres isora. Fitoterapia 2007; 78: 146-8.
4. Otake T, Mori H, Morimoto M, Ueba N, Sutardjo S, Kusomoto II, et al. Screening of Indonesian plant extracts for anti human immuno defciency virus type1 (HIV-1) activity. Phytother Res 1995; 9: 6-10.
5. Pohocha N, Grampurohit ND. Antispasmodic activity of the fruits of Helicteres isora Linn. Phytother Res 2001; 15: 49-52.
6. Chakrabarti R, Vikramadithyan RK, Mullangi R, Sharma VM, Jagadheshan H, Rao YN, et al. Antidiabetic and hypolipidemic activity of Helicteres isora in animal models. J Ethnopharmacol 2002; 81: 343-9.
7. Venkatesh S, Reddy GD, Reddy BM. Antihyperglycemic activity of Helicteres isora roots in alloxan-induced diabetic rats. Pharm Biol 2003; 41: 347-50.
8. Venkatesh S, Reddy GD, Reddy YS, Sathyavathy D, Reddy BM. Effect of Helicteres isora root extracts on glucose tolerance in glucose-induced hyperglycemic rats. Fitoterapia 2004; 75: 364-7.
9. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 2005; 36: 697-705.
10. Coates A, Hu Y, Bax R, Page C. The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 2002; 1: 895-910.
11. Clemett D, Markham A. Linezolid. Drugs 2000; 59: 815-27; discussion 828.
12. Shriram V, Jahagirdar S, Latha C, Kumar V, Puranik V, Rojatkar S, et al. A potential plasmid-curing agent 8-epidiosbulbin E acetate from Dioscorea bulbifera L. against multi-drug resistant bacteria. Int J Antimicrob Agents 2008; 32: 405-10.
13. Jones RN, Della-Latta P, Lee LV, Biedenbach DJ. Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2002; 42: 137-9.
14. Wilson P, Andrews JA, Charlesworth R, Walesby R, Singer M, Farrell DJ, et al. Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 2003; 51: 186-8.
15. Schelz Z, Molnar J, Hohmann J. Antimicrobial and antiplasmid activities of essential oils. Fitoterapia 2006; 77: 279-85.
16. Molnar A, Amaral L, Molnar J. Antiplasmid effect of promethazine in mixed bacterial cultures. Int J Antimicrob Agents 2003; 22: 217-22.
17. Newman DJ, Cragg GM, Snader KM. The infuence of natural products upon drug discovery. Nat Prod Rep 2000; 17: 215-34.
18. Lakshmi VV, Padma S, Polasa H. Elimination of multidrug-resistant plasmid in bacteria by plumbagin, a compound derived from a plant. Curr Microbiol 1987; 16: 159-61.
19. Belofsky G, Percivill D, Lebis K, Tegos GP, Ekart J. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod 2004; 67: 481-4.
20. Beg AZ, Ahmad I. Effect of Plumbago Zeylinica extract and certain curing agents on multidrug resistance bacteria of clinical origin. World J Microb Biotech 2004, 16: 841-4.
21. Marquez B, Neuville L, Moreau NJ, Genet JP, dos Santos AF, Cano de Andrade MC, et al. Multidrug resistance reversal agent from Jatropha ellliptica. Phytochemistry 2005; 66: 1804-11.
22. Bauer AW, Kirby WN, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardised single disc method. Am J Clin Path 1966; 45: 493-6.
23. Lorian V. Antibiotics in laboratory medicine. Baltimore: The Williams and Wilkins Company; 1991. p. 1-51.
24. Deshpande NM, Dhakephalkar PK, Kanekar PP. Plasmid-mediated dimethoate degradation in Pseudomonas aeruginosa MCMB-427. Lett App Microbiol 2001; 33: 275-9.
25. Hirota Y. The effect of acridine dyes on mating type factors in Escherichia coli. Proc Natl Acad Sci USA 1960; 46: 57-64.
26. Watanabe T, Nishida H, Ogata C, Arai T, Sato S. Episome-mediated transfer of drug resistance in Enterobacteriaceae. VII. Two type of naturally occurring R factors. J Bacteriol 1964; 88: 716-26.
27. Trevors JT. Plasmid curing in bacteria. FEMS Microbiol Rev 1986; 32: 149-57.